Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven Single Dose vs Multiple Dose vs FEIBA for Home Treatment of Joint Bleeds
NCT00108797Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2001
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by Novo Nordisk. Started Sep 2001; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT00108797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108797.